Scancell (LON:SCLP) Share Price Crosses Below 200 Day Moving Average - What's Next?

Scancell Holdings plc (LON:SCLP - Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 12.24 ($0.16) and traded as low as GBX 8.10 ($0.10). Scancell shares last traded at GBX 8.50 ($0.11), with a volume of 329,311 shares changing hands.

Scancell Stock Up 1.8 %

The firm has a market capitalization of £88.04 million, a PE ratio of -13.03 and a beta of 0.35. The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of -566.79. The stock has a 50 day simple moving average of GBX 9.15 and a 200 day simple moving average of GBX 12.24.

Scancell (LON:SCLP - Get Free Report) last announced its quarterly earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. As a group, sell-side analysts forecast that Scancell Holdings plc will post -2.5361112 earnings per share for the current year.

Scancell Company Profile

Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.